Anandi Lobo, Sourav K Mishra, Shilpy Jha, Ankit Tiwari, Rahul Kapoor, Shivani Sharma, Seema Kaushal, N Sri Kiranmai, M Rakshitha Das, Kamal P Peddinti, Shailendra K Sharma, Nitin Bhardwaj, Samriti Arora, Deepika Jain, Ekta Jain, Gauri Munjal, Sayali Shinde, Vipra Malik, Hena Singh, Juhi Varshney, Dinesh Pradhan, Mallika Dixit, Niharika Pattnaik, Ashish K Sharma, Yogesh R Barapatre, Manas Pradhan, Kaliprasad Satapathy, Debadarshi Rath, Sunil Jaiswal, Stithi Das, Chiraranjan Khadenga, Sudhasmita Routa, Manas R Baisakh, Romila Tiwari, Nakul Y Sampat, Indranil Chakrabarti, Anil V Parwani, Sambit K Mohanty
OBJECTIVES: Penile squamous cell carcinomas (PCs) are rare malignancies with a dismal prognosis in a metastatic setting; therefore, novel immunotherapeutic modalities are an unmet need. One such modality is the immune checkpoint molecule programmed cell death ligand 1 (PD-L1). We sought to analyze PD-L1 expression and its correlation with various clinicopathologic parameters in a contemporary cohort of 134 patients with PC. METHODS: A cohort of 134 patients with PC was studied for PD-L1 immunohistochemistry...
August 28, 2023: American Journal of Clinical Pathology